Pulmonary Infections and Immunity PDF
Preview Pulmonary Infections and Immunity
Pulmonary Infections and Immunity INFECTIOUS AGENTS AND PATHOGENESIS Series Editors: Mauro Bendinelli, University 01 Pisa Herman Friedman, University 01 South Florida COXSACKIEVIRUSES A General Update Edited by Mauro Bendinelli and Herman Friedman FUNGAL INFECTIONS AND IMMUNE RESPONSES Edited by Juneann W. Murphy, Herman Friedman, and Mauro Bendinelli MYCOBACTERIUM TUBERCULOSIS Interactions with the Immune System Edited by Mauro Bendinelli and Herman Friedman NEUROPATHOGENIC VIRUSES AND IMMUNITY Edited by Steven Specter, Mauro Bendinelli, and Herman Friedman PSEUDOMONAS AERUGINOSA AS AN OPPORTUNISTIC PATHOGEN Edited by Mario Campa, Mauro Bendinelli, and Herman Friedman PULMONARY INFECTIONS AND IMMUNITY Edited by Herman Chmel, Mauro Bendinelli, and Herman Friedman VIRUS-INDUCED IMMUNOSUPPRESSION Edited by Steven Specter, Mauro Bendinelli, and Herman Friedman A Continuation Order Plan is available for this series. A continuation order will bring delivery of each new volume immediately upon publication. Volumes are billed only upon actual shipment. For further information please contact the publisher. Pulmonary Infections and Immunity Edited by Herman Chmel St. Francis Medical Center Trenton, New Jersey Mauro Bendinelli University of Pisa Pisa, Italy and Herman Friedman University oj South Florida Tampa, Florida Springer Science+Business Media, LLC Library of Congress Cataloglng-In-Publlcatlon Data Pulmonary Infections and Immunity I edited by Herman Chmel, Mauro Bendinelll, and Herman Friedman. p. cm. -- (Infectious agents and pathogenesis) Includes bibliographical references and Index. 1. Respiratory Infectlons--Immunologlcal aspects. I. Chmel, Herman. II. Bendinelll, Mauro. III. Friedman, Herman, 1931- IV. Series. [ONLM: 1. Respiratory Tract Infectlons--Immunology. 2. Lung Olseases--Immunology. WF 140 P9828 19941 RC740.P85 1994 616.2'00479--dc20 ONLM/DLC for Library of Congress 94-15377 CIP ISBN 978-1-4899-1065-3 ISBN 978-1-4899-1063-9 (eBook) DOI 10.1007/978-1-4899-1063-9 © 1994 Springer Science+Business Media New York Originally published by Plenum Press, New York in 1994. Softcover reprint of the hardcover 1s t edition 1994 All rights reserved No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise, without written permission from the Publisher Contributors JOHN G. BARTLETT • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 ROBERT W BRADSHER • Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199 MIRIAM L. CAMERON • Division of Infectious Diseases, Duke U niversity Medical Center, Durham, North Carolina 27710 RAMON G. CANTO • Pulmonary/Critical Care Division, The Pennsylvania State University, M. S. Hershey Medical Center, Hershey, Pennsylvania 17033 STANLEY W CHAPMAN • Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505 RICHARD D. CLOVER • Department of Family Medicine, The U niversity of Texas Medical Branch at Galveston, School of Medicine, Galveston, Texas 77555-0853 S. J. CRYZ, JR. • Swiss Serum and Vaccine Institute, CH 3001 Berne, Switzer land BURKE A. CUNHA • Infectious Disease Division, Winthrop-University Hos pital, Mineola, New York 11501; and SUNY School ofMedicine, Stony Brook, New York 11790 STANLEY C. DERESINSKI • Department of Medicine, Stanford University School of Medicine, Stanford, California, 94305; Department of Medicine, Santa Clara Valley Medical Center, San Jose, California 95128; and AIDS Community Research Consortium, Redwood City, California 94062 JERROLD J. ELLNER • Department of Medicine, Case Western Reserve Uni versity and University Hospitals, Cleveland, Ohio 44106-4984 LOUIS F. FRIES • Univax Biologics, Inc., Rockville, Maryland 20852 v vi CONTRIBUTORS ANN W. FUNKHOUSER • Laboratory of Infectious Disease, National Insti tute of Allergy and Infectious Disease, Bethesda, Maryland 20892 ELLIE J. C. GOLDSTEIN • Department of Medicine, Pulmonary Division and Infectious Disease Division, St. john's Hospital and Health Center, Santa Monica, California 90404; and UCLA School of Medicine, Los Angeles, California, 90024 RICHARD H. GOLDSTEIN • Department of Medicine, Pulmonary Division and Infectious Disease Division, St. john's Hospital and Health Center, Santa Monica, California 90404; and UCLA School of Medicine, Los Angeles, California, 90024 HAROLD M. HENDERSON • Division of Infectious Diseases, University of Mississippi Medical Center, jackson, Mississippi 39216-4505 CAROL A. KEMPER • Department of Medicine, Stanford University School of Medicine, Stanford, California 94305; Department of Medicine, Santa Clara Valley Medical Center, Sanjose, California 95128; and AIDS Commu nity Research Consortium, Redwood City, California 94062 GERALD LANCZ • Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa, Florida 33612 RICHARD W. MCDONNELL • Department of Medicine, University of Ar kansas for Medical Sciences, Little Rock, Arkansas 72205-7199 JOHN R. PERFECT • Division of Infectious Diseases, Duke University Medi cal Center, Durham, North Carolina 27710 HERBERT Y. REYNOLDS • Department of Medicine, The Pennsylvania State University, M. S. Hershey Medical Center, Hershey, Pennsylvania 17033 GEORGE R. ROBINSON 11 • Pulmonary/Critical Care Division, The Pennsyl vania State University, Hershey, Pennsylvania 17033 LORRY G. RUBIN • Department ofPediatrics, Schneider Children's Hospital of Long Island jewish Medical Center, Long !sland Campus for the Albert Einstein College of Medicine, New Hyde Park, New York, 11042 DAVID H. SHEPP • Department of Medicine, North Shore University Hospi tal, Cornell University Medical College, Manhasset, New York 11030 STEVEN SPECTER • Department of Medical Microbiology and Immunol ogy, University of South Florida College of Medicine, Tampa, Florida 33612 RICHARD V. SPERA,jR. • Department ofMedicine, North Shore University Hospital, Cornell University Medical College, Manhasset, New York 11030. Present address: Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, New York 11201 CONTRIBUTORS Vll JANET E. STOUT • Special Pathogens Laboratory, Pittsburgh, Pennsylvania 15261 FREDERICK R. VOGEL • Vaccine Research and Development Branch, Divi sion of AIDS, Department of Health and Human Services, National Insti tutes of Health, Bethesda, Maryland 20892 ROBERT S. WALLIS • Department of Medicine, Case Western Reserve Uni versity and University Hospitals, Cleveland, Ohio 44106-4984 VICTOR L. YU • University of Pittsburgh, Infectious Disease Section, VA Medical Center, Pittsburgh, Pennsylvania 15240 Preface to the Series The mechanisms of disease production by infectious agents are presently the focus of an unprecedented ßowering of studies. The field has undoubtedly received impetus from the considerable advances recently made in the under standing of the structure, biochemistry, and biology of viruses, bacteria, fungi, and other parasites. Another contributing factor is our improved knowledge of immune responses and other adaptive or constitutive mechanisms by which hosts react to infection. Furthermore, recombinant DNA technology, monoclonal anti bodies, and other newer methodologies have provided the technical tools for examining questions previously considered too complex to be successfully tackled. The most important incentive of all is probably the regenerated idea that infection might be the initiating event in many clinical entities presently classified as idiopathic or of uncertain origin. Infectious pathogenesis research holds great promise. As more information is uncovered, it is becoming increasingly apparent that our present knowledge of the pathogenic potential of infectious agents is often limited to the most notice able effects, which sometimes represent only the tip of the iceberg. For example, it is now weIl appreciated that pathological processes caused by infectious agents may emerge clinically after an incubation of decades and may result from genetic, immunologic, and other indirect routes more than from the infecting agent itself. Thus, there is a general expectation that continued investigation will lead to the isolation of newagents of infection, the identification of hitherto unsuspected etiologic correlations, and eventually, more effective approaches to prevention and therapy. Studies on the mechanisms of disease caused by infectious agents demand a breadth of understanding across many specialized areas, as weIl as much cooper ation between clinicians and experimentalists. The se ries Infectious Agents ix x PREFACE TO THE SERIES and Patlwgenesis is intended not only to document the state of the art in this fascinating and challenging field but also to help lay bridges among diverse areas and people. M. Bendinelli H. Friedman
The list of books you might like
